SEC Form 4 · accession 0001415889-15-002978
ACADIA PHARMACEUTICALS INC · ACAD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen Davis
Officer — PRESIDENT AND CEO · Director
Period of report
Sep 1, 2015
Accepted (ET)
Sep 3, 2015 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070494
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $35.91 | Sep 1, 2015 | A | 225,000 | A | — | Aug 31, 2025 | Common Stock | 225,000 | 225,000 | D |
Explanation of responses
- F125% of the shares subject to the Stock Option vest 1 year after the date of grant, with 1/48th of the shares vesting after each the following 36 months.